TB Mobile: a mobile app for anti-tuberculosis molecules with known targets

MDR-TB Has New Drug Foe After Fast-Track Approval

(2013) Rebecca Voelker   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening

(2012) Sarah A. Stanley et al.   ACS Chemical Biology

A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis

(2012) Puiying A. Mak et al.   ACS Chemical Biology

targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis

(2012) Karthik Raman et al.   BMC Systems Biology

Towards a new tuberculosis drug: pyridomycin - nature's isoniazid

(2012) Ruben C. Hartkoorn et al.   EMBO Molecular Medicine

Redefining Cheminformatics with Intuitive Collaborative Mobile Apps

(2012) Alex M. Clark et al.   Molecular Informatics

Combining Cheminformatics Methods and Pathway Analysis to Identify Molecules with Whole-Cell Activity Against Mycobacterium Tuberculosis

(2012) Malabika Sarker et al.   PHARMACEUTICAL RESEARCH

A High-Throughput Screen Identifies a New Natural Product with Broad-Spectrum Antibacterial Activity

(2012) Patrick Ymele-Leki et al.   PLoS One

Identification of Novel Mt-Guab2 Inhibitor Series Active against M. tuberculosis

(2012) Veeraraghavan Usha et al.   PLoS One

High-throughput Screening and Sensitized Bacteria Identify an M. tuberculosis Dihydrofolate Reductase Inhibitor with Whole Cell Activity

(2012) Anuradha Kumar et al.   PLoS One

Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials

(2012) B. Gold et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Challenges and opportunities in developing novel drugs for TB

(2011) Takushi Kaneko et al.   Future Medicinal Chemistry

The challenge of new drug discovery for tuberculosis

(2011) Anil Koul et al.   NATURE

Impact of high-throughput screening in biomedical research

(2011) Ricardo Macarron et al.   NATURE REVIEWS DRUG DISCOVERY

New Classes of Alanine Racemase Inhibitors Identified by High-Throughput Screening Show Antimicrobial Activity against Mycobacterium tuberculosis

(2011) Karen G. Anthony et al.   PLoS One

Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis

(2011) W. Shi et al.   SCIENCE

Genetic Requirements for the Survival of Tubercle Bacilli in Primates

(2010) Noton K. Dutta et al.   JOURNAL OF INFECTIOUS DISEASES

Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis

(2010) Sean Ekins et al.   Molecular BioSystems

Current development and future prospects in chemotherapy of tuberculosis

(2010) Eric L. NUERMBERGER et al.   RESPIROLOGY

Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery

(2010) Sean Ekins et al.   TRENDS IN MICROBIOLOGY

Basic primitives for molecular diagram sketching

(2010) Alex M Clark   Journal of Cheminformatics

Target Fishing for Chemical Compounds Using Target-Ligand Activity Data and Ranking Based Methods

(2009) Nikil Wale et al.   Journal of Chemical Information and Modeling

Fishing the Target of Antitubercular Compounds:In SilicoTarget Deconvolution Model Development and Validation

(2009) Philip Prathipati et al.   JOURNAL OF PROTEOME RESEARCH

High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors

(2009) Thierry Christophe et al.   PLoS Pathogens

TB database: an integrated platform for tuberculosis research

(2008) T. B. K. Reddy et al.   NUCLEIC ACIDS RESEARCH

Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis

(2007) James C. Sacchettini et al.   NATURE REVIEWS MICROBIOLOGY